GXP

Improving Microbiological Control Of Non-Sterile Pharmaceuticals: Unlocking The FDA Guidance

The document is the first time that the FDA has pieced together a compliance framework for non-sterile medicines, and, in some ways, the document stands as a companion piece to the Aseptic Processing Guidance (issued in 2004, although in clear need of an update). The trigger for the non-sterile document was based on the pattern of non-sterile product recalls involving microbial contamination, based on the period 2014 to 2017 when 197 bacterial and fungal contamination events, associated with either the manufacture, packaging, shipping, or storage of the drug, were recorded. The FDA considers the...

This content is only available to IVT members.
Get help maintaining your knowledge . Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.




Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.